Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals Private Limited - pharma in Roha, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1978PTC020535 Incorporated 31 July 1978 ROC Mumbai HQ Roha, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹5.12 Cr
▲ 11% YoY
Net profit · FY 2025
₹1.06 Cr
Net margin 20.7%
EBITDA · FY 2025
₹1.56 Cr
EBITDA margin 30.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹56,500
Issued & subscribed
Company age
48 yrs
Est. 1978
Employees · EPFO
56
Provident fund records
Directors on board
2
As per MCA filings

About Spectrum Pharmaceuticals Private Limited

Data last updated:

Spectrum Pharmaceuticals Private Limited is a private limited company based in Roha, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 July 1978 and has been in existence for over 48 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1978PTC020535. Its GSTIN is 27AAECS5733P1ZR (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹56,500. It is led by directors Laxman Sitaram Ufale and Anil Nivrutti Dumbre.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 52 MIDC Area Dhatav Roha, Maharashtra, India – 402116.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.12 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.06 Cr (net margin 20.7%) and EBITDA of ₹1.56 Cr (EBITDA margin 30.5%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 8% over five years.

The company has about 56 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Spectrum Pharmaceuticals Private Limited
CIN U24230MH1978PTC020535
Registration Number 020535
Incorporation Date 31 July 1978
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Laxman Sitaram Ufale Director Anil Nivrutti Dumbre Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No 52 MIDC Area Dhatav Roha, Maharashtra, India – 402116
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Spectrum Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Spectrum Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Spectrum Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Spectrum Pharmaceuticals Private Limited

The main business activity of Spectrum Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparationsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Spectrum Pharmaceuticals Private Limited FY 2025 filings available

Spectrum Pharmaceuticals Private Limited reported revenue of ₹5.12 Cr (up 11% YoY) for FY 2025.

Revenue · FY 2025
₹5.12 Cr ▲ 11%
Net profit · FY 2025
₹1.06 Cr margin 20.7%
EBITDA · FY 2025
₹1.56 Cr margin 30.5%

Compounded Annual Growth Rate (CAGR) of Spectrum Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 22%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 112%
3 years · compounded
▲ 134%
5 years · compounded
▲ 48%

Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 11% growth in the latest year. EBITDA rose 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Spectrum Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.56 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.06 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Spectrum Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin30.5%••••••••••••••••
Net Profit Margin20.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Spectrum Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Biocrit Healthcare Private Limited₹5.14 Cr (FY 2025)••••••••108.0%••••Pune, Maharashtra, India
Amnion Biosciences Private Limited₹5.14 Cr (FY 2024)••••••••-18.0%••••Bangalore, Karnataka, India
Synim Remedies Private Limited₹5.13 Cr (FY 2024)••••••••14.0%••••Hyderabad, Telangana, India
Baxton Pharmacia Private Limited₹5.13 Cr (FY 2025)••••••••8.0%••••Chandigarh, India
Life Pharmaceuticals Pvt Ltd₹5.12 Cr (FY 2025)••••••••-31.0%••••Kolkata, West Bengal, India
Spectrum Pharmaceuticals Private Limited this company₹5.12 Cr (FY 2025)••••••••11.0%••••Roha, Maharashtra, India
Gripil Pharmaceuticals Private Limited₹5.12 Cr (FY 2024)••••••••-30.0%••••Vasai, Maharashtra, India
Raddison Healthcare Private Limited₹5.11 Cr (FY 2025)••••••••15.0%••••Uttar Pradesh, India
Atlanta Biological Private Limited₹5.1 Cr (FY 2025)••••••••149.0%••••Kolkata, West Bengal, India
Yug Pharmaceuticals Private Limited₹5.09 Cr (FY 2025)••••••••219.0%••••New Delhi, Delhi, India
Nexina Healthcare Private Limited₹5.08 Cr (FY 2025)••••••••52.0%••••Ahmedabad, Gujarat, India

Peers are the five companies nearest above and the five nearest below Spectrum Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals Private Limited is audited by D Y & ASSOCIATES for the financial year 2020.

NameStatusAppointment DateCessation Date
D Y & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Laxman Sitaram Ufale
Also directs: Amaysr Laboratories Private Limited, Krisp Laboratories Private Limited
Director30 Oct 20232 Years 11 MonthsCurrent
Anil Nivrutti Dumbre
Also directs: Amaysr Laboratories Private Limited, Krisp Laboratories Private Limited
Director14 Jul 20224 Years 2 MonthsCurrent
View all directors

Ownership and Shareholding of Spectrum Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals Private Limited has a workforce of 56 employees as of Apr 08, 2024.

Employee count
56
Active EPFO establishments
1
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Group Structure of Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals has 2 subsidiary companies and 1 associated company. This group structure data is as of FY 2020. The table lists each entity with its relationship and holding.

2
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company NameCINShares Held
Amaysr Laboratories Private LimitedU24299MH2019PTC333603Locked
Krisp Laboratories Private LimitedU99999MH1986PTC040344Locked

Showing major subsidiaries. Total: 2.

Recent Activity on Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals Private Limited has 8 board changes on record since 2012: 2 appointments and 6 cessations. The latest: Laxman Sitaram Ufale was appointed as Director on 30 Oct 2023.

AGM
Spectrum Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Spectrum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Laxman Sitaram Ufale was appointed as Director.
Ceased
Anil Nivrutti Dumbre ceased to be Additional Director.
Appointed
Anil Nivrutti Dumbre was appointed as Director.
Ceased
Vikas Radheshyam Bhavsar ceased to be Director.
Ceased
Seema Anil Palande ceased to be Additional Director.
Ceased
Ravi Chettuvatty Menon ceased to be Director.
Ceased
Laxman Sitaram Ufale ceased to be Director.
Ceased
Jayaprakash Ramanath Chandragiri ceased to be Director.
Incorporation
31 Jul 1978
Spectrum Pharmaceuticals Private Limited was registered on 31 Jul 1978 with Roc Mumbai Ii & aged 48 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Spectrum Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Spectrum Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Spectrum Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECS5733P1ZRMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Spectrum Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Spectrum Pharmaceuticals Private Limited

Spectrum Pharmaceuticals is an active private limited company based in Roha, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 July 1978 (48+ years old) and is registered under CIN U24230MH1978PTC020535.

Spectrum Pharmaceuticals reported revenue of ₹5.12 Cr for FY 2025 (up 11% YoY).

Spectrum Pharmaceuticals has 2 current directors:

Spectrum Pharmaceuticals reported a net profit of ₹1.06 Cr (net margin 20.7%) and EBITDA of ₹1.56 Cr (EBITDA margin 30.5%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Spectrum Pharmaceuticals is 22% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Spectrum Pharmaceuticals is 27AAECS5733P1ZR, registered in Maharashtra.

The CIN (Corporate Identification Number) of Spectrum Pharmaceuticals is U24230MH1978PTC020535. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Spectrum Pharmaceuticals has 3 court cases on record: 3 filed by the company. 3 are pending.

Spectrum Pharmaceuticals was incorporated on 31 July 1978, making it 48+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Spectrum Pharmaceuticals by revenue are Biocrit Healthcare Private Limited, Amnion Biosciences Private Limited, Synim Remedies Private Limited, Baxton Pharmacia Private Limited, Life Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).

Laxman Sitaram Ufale was appointed as Director on 30 Oct 2023. Anil Nivrutti Dumbre ceased to be Additional Director on 08 Aug 2022. Anil Nivrutti Dumbre was appointed as Director on 14 Jul 2022. Spectrum Pharmaceuticals has 8 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available